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28 Abstract: 
29 Objectives:
30 We aimed to compare risk factors for adverse pregnancy outcomes in women living with 
31 HIV (WLWH) with women of the general population (WGP) in Denmark. Further, we 
32 estimated risk of pregnancy- or birth-related complications.
33 Methods:
34 A retrospective cohort study including all WLWH who delivered a live-born child from 
35 2002-2014 and controls, matched by origin, age, year and parity. We compared risk 
36 factors during pregnancy and estimated risk of pregnancy- and birth-related complications 
37 using multivariate logistic regression.  
38 Results:
39 A total of 2,334 pregnancies in 304 WLWH and 1,945 WGP were included. WLWH had 
40 more risk factors present during pregnancy: previous caesarean section (CS) (24.7% vs 
41 16.3%; p=0.0001), smoking (14.2% vs 7.5%; p=0.0001) and previous perinatal/neonatal 
42 death (2.3% vs 0.9%; p=0.03).
43 We found no difference between groups regarding gestational diabetes, hypertensive 
44 disorders, low birth weights or premature delivery. More children of WLWH had 
45 intrauterine-growth-retardation (IUGR) (aOR 1.9 95%CI; 1.1-3.2; p=0.02). Median 
46 gestational age and birth weights were lower in children born to WLWH. 
47 WLWH had higher risk of emergency CS (EmCS) (aOR 1.6 95%CI; 1.2-2.1; p=0.0005) and 
48 postpartum haemorrhage (aOR 1.4 95%CI; 1.0-1.9; p=0.02) but not infection, amniotomy, 
49 failure to progress, low APGAR scores or signs of asphyxia. 
50 Conclusion: 
51 WLWH had more risk factors present during pregnancy, similar risk of most pregnancy- 
52 and birth-related complications but a higher risk of postpartum haemorrhage and EmCS 
53 than WGP. Children born by WLWH had lower median birth weights and gestational age 
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56 Introduction 
57 Management of pregnant woman with HIV infection has evolved significantly over the past 
58 25 years in light of advancements in antiretroviral therapy (ART) and a better 
59 understanding of the prevention of perinatal HIV transmission. In the United States and 
60 Europe the risk of mother-to-child transmission (MTCT) in women living with HIV (WLWH) 
61 with viral suppression and who do not breastfeed is <1% independently of mode of 
62 delivery (1-3). 
63 Pregnancy in WLWH compared with women of the general population (WGP) has been 
64 associated with several adverse outcomes to both mothers and infants (4, 5). Possible 
65 maternal complications include preeclampsia, gestational diabetes and premature rupture 
66 of membranes (PROM). Moreover the birth itself brings the mother at risk of several other 
67 harmful events including emergency caesarean section (EmCS), post-partum-bleeding 
68 and infections (6-10). Previous studies have shown that children born by WLWH are at 
69 higher risk of prematurity, asphyxia, growth-restriction and low birth weight (6, 11, 12). 
70 However much of the research have shown contradictory results (5, 6, 11, 13-15), which 
71 may be explained by differences in national recommendations and changing guidelines 
72 regarding ART and mode of delivery. It has been questioned if pregnant WLWH 
73 constitutes a subpopulation with risk factors beyond HIV causing bias to results (9)
74 Vaginal delivery is a safe mode of delivery in WLWH with viral suppression and does not 
75 increase risk of MTCT (3, 10, 16). However, far more WLWH still deliver by caesarean 
76 section (CS) including elective caesarean section (ECS) and EmCS compared to WGP 
77 (16). CS and especially EmCS increase risk of complications to both mothers and children 
78 (10, 17). The risk of complication is likely to be higher in WLWH with impaired immune 
79 function (4). However with ART and the restoration of immune function it is possible that 
80 the previous shown risks of complications are no longer present. 
81 This study aimed to compare known risk factors in pregnancy between WLWH and their 
82 matched controls. Further we examined if WLWH and their children are in greater risk of 
83 complications related to pregnancy and birth and whether the differences in complications 
84 could be explained by mode of delivery or risk factors during pregnancy.
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86 Study design and population 
87 The study design and population is described in a previous study regarding mode of 
88 delivery (16). We conducted a retrospective matched cohort study including all WLWH 
89 giving birth to live born children in Denmark between 1 January 2002 and 31 December 
90 2014. Exclusion criteria were HIV diagnosis after delivery, unknown mode of delivery or 
91 invalid Personal Identification Number (PIN), a unique 10-digit number assigned all Danish 
92 residents at birth or immigration. Only singleton pregnancies were included and every 
93 pregnancy was treated as a separate case. WLWH were divided in three groups due to a 
94 change in guidelines in 2007 where vaginal delivery was accepted in WLWH with VL < 
95 1000 copies/mL (2002-2006, 2007-2008 and 2009-2014). Using the Danish Medical Birth 
96 Registry WLWH were individually matched at random 1:5 on maternal origin, age at 
97 delivery and parity to WGP. Women with unknown parity were set to be nulliparous. HIV 
98 characteristics on WLWH were extracted from medical records (16). Using the PIN, we 
99 linked to the following registries: 
100 The Medical Birth Registry 
101 In the Medical Birth Registry we retrieved information regarding date of birth, gestational 
102 age, birth weight and pregnancy- and birth-related complications. 
103 The National Patient Registry
104 We used the National Patient Registry to extract all diagnoses regarding pregnancy, 
105 comorbidities and other risk factor during pregnancy, birth and complications to pregnancy 
106 or birth with the International Classification of Diseases, 10th revision (ICD-10) codes; 
107 DO0-999 and DZ3-399. 
108 Statistics Denmark
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112 The primary outcomes of this study were risk factors during pregnancy comparing WLWH 
113 and WGP; including high body mass index (BMI >25), smoking, prior perinatal deaths, 
114 prior CS, viral hepatitis (chronic hepatitis B and C) and psychiatric disorders (DO993B1-5). 
115 Secondary outcomes were pregnancy- or birth-related complications. 
116 Pregnancy-related complications included: premature rupture of membranes (PROM, <37 
117 weeks) and preterm premature rupture of membranes (PPROM, <37 weeks) due to the 
118 possibility of prolonged birth (>6 hours) and an subsequent risk of EmCS, intrauterine 
119 growth retardation (IUGR) or placental insufficiency (DO365A-E), gestational diabetes 
120 mellitus (GDM), hypertensive disorders (pre-eclampsia, eclampsia, hemolysis elevated 
121 liver enzymes low platelets syndrome (HELLP syndrome), preterm delivery (<37 weeks) 
122 and birth weight <2500 grams. 
123 Birth related complications included amniotomy, failure to progress (DO62-639), 
124 indications of/and asphyxia (DO363+DO68-688), low Activity-Pulse-Grimace-Appearance-
125 Respiration (APGAR) score, perineal laceration (2th - 4th degree or episiotomy), EmCS 
126 (DO821A-C), postpartum haemorrhage (>500 mL) and infections (DO86-DO869, i.e. all 
127 post-partum infections, including urinary tract infections, endometriosis, wound infections 
128 etc.). 
129 Statistical analyses 
130 Categorical variables were reported as counts and percentages and compared by chi-
131 square test- or Fisher’s exact test, as appropriate. Continuous variables were summarized 
132 as mean and 95% confidence intervals (CI) or median and interquartile range (IQR) and 
133 compared using Wilcoxon rank sum test. 
134 Individual multivariate logistic regression was performed to identify differences in risk of 
135 complications. Odds ratios (ORs) and CI were estimated and adjusted a priori. Pregnancy 
136 related complications were adjusted for viral hepatitis, smoking, psychiatric disorders, age 
137 ≥30 years and parity. Low birth weight was additionally adjusted for prematurity. Birth 
138 related complications were adjusted for smoking, age ≥30 years, parity, previous CS, year 
139 and mode of delivery. Failure to progress, amniotomy and perineal lacerations were only 
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141 combined p-value was estimated for variables spending more than one degree of freedom 
142 in the logistic regression. Individuals with missing explanatory values were excluded from 
143 the multivariate regression analyses. The validity of the model was tested using the 
144 Hosmer and Lemeshow Goodness-of-Fit Test. SAS statistical software version 9.3 (SAS 
145 Institute Inc., Cary, NC, USA) was used for data analysis and p-values <0.05 (two-sided) 
146 were considered statistically significant. 
147 Ethics
148 The project was approved by the Danish Data Protection (J.no. 2012-41-0904), the 
149 National Board of Health (J.no. 7-604-04-2/4) and the Danish Patient Safety Authority 
150 (case no. 3-3013-406/1-3). According to Danish law, approval from the National 
151 Committee on Health Research Ethics was not required as no biomedical interventions 
152 were performed. 
153 Results 
154 Baseline: 
155 There were 406 HIV pregnancies resulting in live births in the study period, 17 were 
156 excluded due to either multiple pregnancies (n=6) or missing PIN (n=11) leaving 389 
157 pregnancies in 304 WLWH for analysis. The pregnancies were matched to 1,945 singleton 
158 pregnancies in WGP. Baseline characteristics are listed in Table 1. 
159 All WLWH were on ART at time of delivery; primarily on a combination regimen of 2 
160 nucleoside reverse-transcriptase inhibitors and a protease inhibitor (PI) (73.8 %). The main 
161 PI’s used were Ritonavir/Lopinavir (n=145, 37.3%) or Ritonavir/Atazanavir (n=71, 18,3%). 
162 At delivery 85.6 % of WLWH had HIV-RNA <40 copies/mL and 6 (1.5%) women had HIV-
163 RNA >1000 copies/mL. 
164 Risk factors present during pregnancy
165 WLWH presented with more risk factors than WGP during pregnancy: smoking (14.2 % vs. 
166 7.5 %; p<0.0001), previous CS (36.7 % vs. 24.6 %; p=0.0001) and previous 
167 perinatal/neonatal death (3.9 % vs. 0.6 %; p=0.009). Furthermore, a larger proportion of 
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169 disorder (4.7 % vs. 2.6 %; p<0.02). Fewer WLWH had BMI >25 (32.9 % vs. 39.2 %; 
170 p<0.04). The comparison of risk factors present during pregnancy between WLWH and 
171 WGP is presented in Table 2. 
172 Complications 
173 Pregnancy related complications
174 As illustrated in Table 3, no significant differences were found between WLWH and WGP 
175 regarding GDM (3.6 % vs 3.7 %, aOR 1.0 (95%CI; 0.5-1.9) p=0.95), PROM/PPROM  (8.0 
176 % vs 6.3 %, aOR 1.2 (95%CI; 0.8-1.9) p=0.32), hypertensive disorders (1.8 % vs 3.7 %, 
177 aOR 0.6 (95%CI; 0.3-1.2) p=0.15), premature delivery (9.7 % vs 5.8 %, aOR 1.5 (95%CI; 
178 0.9-2.2) p=0.09) or birth weight below 2500 grams (8.6 % vs 4.9 % aOR 1.3 (95%CI; 0.7-
179 2.4) p=0.43). We did however; find more children with IUGR born to WLWH (5.5 % vs 3.1 
180 %, aOR 1.9 (95%CI; 1.1-3.2) p=0.02). 
181 During the study period the median gestational age of children born to WLWH increased 
182 almost reaching that of children born to WGP (2014: WLWH 39.1 weeks (IQR; 38.4-40.1 
183 weeks) and WGP 39.9 weeks (IQR; 39.3-40.0) p=0.08). Accordingly, birth weights of 
184 children born to WLWH increased. However, measures were still lower than those of 
185 children born to WGP (2014: WLWH median 3,175.0 grams (IQR; 2,975.0-3,566.0) and 
186 WGP median 3,500.0 grams (IQR; 3,004.0-3,850.0) p=0.03) (Figure 1). When stratifying 
187 by mode of delivery, a significant difference was seen only in EmCS where children born 
188 to WLWH were both of smaller gestational age and of lower birth weight (Figure 1a-1c). 
189 Birth related complications 
190 WLWH were in increased risk of having an EmCS performed (26.0 % vs. 17.0 %, aOR 1.6 
191 (95%CI; 1.2-2.1), p=0.0005) and postpartum hemorrhage (29.0 % vs. 25.7 % aOR 1.4 
192 (95%CI; 1.0-1.9), p=0.02). Fewer children born to WLWH showed signs of asphyxia during 
193 birth (8.2 % vs 21.5 %, aOR 0.4 (95%CI; 0.2-0.6), p<0.0001). No significant differences 
194 regarding low APGAR scores or maternal infections were found (2.3 % vs 1.6 %, aOR 0.8 
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196 In women delivering vaginally, there was no significant difference in risk of failure to 
197 progress or perineal lacerations, but fewer WLWH had amniotomies performed (3.8 % vs 
198 17.1 %, aOR 0.2 (95%CI; 0.1-0.5) p=0.0003).
199 Discussion
200 In this nationwide cohort study including all WLWH in Denmark, who gave birth to 
201 singletons in the period 2002-2014, we found that WLWH had another risk profile during 
202 pregnancy, with increased rate of smokers, previous CS, concomitant viral hepatitis and 
203 psychiatric disorders. Despite this, we found no increased risk for most pregnancy- or birth 
204 related complications compared with WGP. However, our data suggest that WLWH are in 
205 higher risk of postpartum haemorrhage and placental insufficiency with more children born 
206 with IUGR. Further WLWH had almost twice the risk of EmCS subsequently having 
207 children with lower birth weight and smaller gestational age compared with WGP. 
208 Pregnancy related complications
209 It is not well established whether HIV contributes to the development of diabetes mellitus 
210 (DM) (18). Some studies have found ART, especially PIs, to increase insulin resistance 
211 (19, 20), and other studies have shown a higher incidence of GDM in WLWH compared 
212 with WGP (6, 20). In our study, most women were treated with PI’s during pregnancy and 
213 we did not find them to be in higher risk of GDM. This suggests that HIV and ART might 
214 not have the speculated impact on the GDM when adjusting for general risk factor. The 
215 lack of difference could be explained by the matching on age and origin and that the 
216 general incidence of GDM in Denmark is low, roughly estimated between 2-3% (21).
217 It has been speculated if WLWH are less likely to produce the excessive immune response 
218 normally seen in pre-eclampsia, and ART by restoring the immune function increases the 
219 risk (7). However recent studies have not been able to confirm this. We found both a low 
220 rate of hypertensive disorders including pre-eclampsia and no significant differences 
221 between groups. In comparison Adams et al. (22), reported that WLWH receiving ART 
222 were not at increased risk of pre-eclampsia and Boyajian et al. (13) found that fewer 
223 WLWH compared with WGP developed pre-eclampsia and only among WLWH with 
224 already established risk factors. Both studies pointed towards WLWH having lower risk of 
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226 findings of a lower risk of developing hypertensive disorders in well-treated WLWH 
227 compared with WGP.
228 Children born by WLWH have previously been shown to have higher rates of low birth 
229 weight and prematurity (6, 11, 12). We did however not find significantly increased risk of 
230 premature delivery or low birth weights in WLWH in the adjusted analyses. The 
231 mechanisms to which HIV contributes to prematurity or low birth weight are not fully 
232 understood but it includes socioeconomic differences, HIV per se, ART and a general 
233 difference in risk factors during pregnancy (9, 23, 24). Since medical care, including ART, 
234 is tax-paid and provided free-of-charge to all people living with HIV in Denmark the 
235 contribution of socioeconomic issues to the results is presumably small compared with 
236 others (25). HIV has been suggested to cause intrauterine growth retardation as seen in 
237 other intrauterine viral infections such as cytomegalovirus (26) and Ackerman et al. (24) 
238 have posited that the viral infection of the placenta might lead to impaired maternal-fetal 
239 exchange or the maternal infection might disrupt normal placental implantation and 
240 development. In our cohort most WLWH were well treated with low HIV viral load. A viral 
241 infection of the placenta seems unlikely and the direct effect of HIV small. 
242 Known risk factors to low birth weight or prematurity includes smoking and mental health 
243 (27, 28) Smoking causes vasoconstriction and placental insufficiency (29) and though the 
244 mechanism is not fully understood maternal mental stress and fetal growth seems to be 
245 associated (28). Aliyu et al. (26) found WLWH, that smoked during pregnancy, had an 
246 increased risk of low birth weight and prematurity compared to both HIV negative non-
247 smokers and smokers, suggesting a possible synergistic intrauterine effect between 
248 smoking and HIV. In our cohort we found WLWH were twice as likely to smoke or suffer 
249 from psychiatric disorder during pregnancy compared to WGP. Both risk factors were 
250 included in the adjusted analysis and the variation could by a contributing factor to why 
251 previous studies have found increased risk of prematurity and low birth weight and why the 
252 difference was not found in our study. 
253 Compared to WGP, children of WLWH had a smaller median gestational age and lower 
254 median birth weight ranging from 100-500 grams below WGP in recent years. This 
255 difference was most pronounced in WLWH delivering by EmCS and could be a result of 
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257 term, thus lowering the birth weight and gestational age. Previously WLWH were 
258 recommended ECS in week 38-39, in 2007 guidelines changed allowing more WLWH to 
259 deliver vaginally and the iatrogenic induced prematurity decreased. Correspondingly, the 
260 median gestational age increased during the study period, similar to other reported 
261 findings (6, 12, 30). 
262 We did not have statistical power to examine the possible effects of ART or compare PI vs. 
263 non-PI regimens on outcomes. Recent studies have associated ART with prematurity and 
264 low birth weight (23, 31-33). In our study all WLWH were in ART at time of delivery and the 
265 vast majority received a PI regimen, and though we did not find increased risk of 
266 prematurity or births weight <2500g, we can not rule out that ART might be contributing to 
267 the lowered gestational age or smaller birth weight found in the study. 
268 IUGR due to placental insufficiency is a major contributor to perinatal morbidity and 
269 mortality (34). WLWH in the present study had almost twice the risk of placental 
270 insufficiency and children with IUGR compared with WGP even after adjusting for smoking 
271 and viral hepatitis. These findings are supported by others who identified low maternal BMI 
272 and previous injection drug use to be more prevalent among IUGR-mothers (34). 
273 Unfortunately, we were not able to adjust for BMI due to a high number of missing values; 
274 however, we found a trend towards a lower BMI in WLWH. Though not investigating IUGR, 
275 Canlorbe et al. (14) found more WLWH having abnormal uterine Doppler results, 
276 increasing risks of placental insufficiency and IUGR. More research addressing IUGR and 
277 placental insufficiency is needed to understand a possible correlation. 
278 Birth complications
279 WLWH have been thought to experience more complications to birth compared with WGP 
280 (4). Possible explanations include differences in mode of delivery where more WLWH 
281 deliver by ECS and a compromised immune system with increased vulnerability to 
282 infections (8). However with increasing experience in surgical techniques, anesthetic and 
283 prophylactic antibiotics some studies have declared elective caesarean section to be as 
284 safe as vaginal delivery (35). Further, WLWH, virally suppressed on ART with a stable CD4 
285 count, would be expected to resemble WGP in risk. Correspondingly, we did not find 
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287 The association between obstetric hemorrhage and HIV is not well established and studies 
288 are conflicting (7, 8). Studies have previously associated CS with a higher risk of 
289 postpartum blood loss (36). In a newer Danish study conducted in WGP, Holm et al. (36) 
290 found that ECS was associated with reduced risk of postpartum haemorrhage compared to 
291 intended vaginal delivery (36). Further the clinical estimates of blood loss during birth are 
292 uncertain and often based on estimates (36) and it s possible that if there are any 
293 complications i.e. EmCS, asphyxia etc. the estimate is higher than if the birth proceeds as 
294 planned. Though the analysis were adjusted for mode of delivery it is possible that in our 
295 cohort where more WLWH deliver by EmCS the result might be biased. Previous CS 
296 section are found to increase risk of postpartum bleeding (37) and as more WLWH have 
297 previously had a CS this might also contribute to the increased risk seen in our study. 
298 In accordance with other studies (9, 12), we found WLWH in increased risk of EmCS 
299 compared with WGP. Predictors of EmCS have been investigated in a previous study (16) 
300 and included PROM, asphyxia, preterm delivery and delivery during evenings/nights. 
301 WLWH only have limited opportunity of vaginal delivery due to guidelines regarding 
302 assisted vaginal delivery, monitoring and rupture of membranes. As a consequence; 
303 WLWH delivering vaginally seem to be a selected group with a reduced risk of birth 
304 complications, since any sign of obstacles result in an EmCS. Children born to WLWH 
305 were less likely to develop signs of asphyxia and mothers undergoing vaginal delivery 
306 were less likely to fail to progress or get perineal lacerations. Correspondingly, Azria et al. 
307 (38) reported that WLWH without contraindications to vaginal delivery had the same birth 
308 outcomes as WGP and that WGP were more likely to have perineal lacerations. The same 
309 trend was seen in our study and could partly be explained by the lack of instrumental use 
310 in WLWH. Since guidelines recommend against amniotomies, significantly less WLWH 
311 had this procedure performed. An Italian multicentre study Floridia et al. (39) did not find 
312 invasive testing during pregnancy to increase risk of vertical transmission in well-treated 
313 women and Cotter et al. (40) did not find rupture of membranes beyond 4 hours to be a 
314 risk factor for transmission and a revision of guidelines could help in increasing the 
315 possibility and safety of vaginal delivery and reduce risk of EmCS and subsequent risk of 
316 other complications. 
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318 Strengths of the present study include the nationwide design including all WLWH and 
319 individually matched controls with near complete information. Furthermore, we used 
320 national registries with prospectively collected data independently of outcome with minor 
321 risk of incorrect registrations (41). The retrospective design limits the study to rely on data 
322 extracted from chart reviews. The relative low number of pregnancies of WLWH was a 
323 limitation and the lack of statistical power to conduct analysis regarding associations 
324 between antiretroviral drugs and adverse outcomes.
325 Conclusion
326 WLWH had more risk factors present during pregnancy, similar risk of most pregnancy- 
327 and birth-related complications but a higher risk of postpartum haemorrhage and EmCS 
328 than WGP. Children born by WLWH had lower median birth weights and gestational age 
329 and were at higher risk of IUGR. 
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Table 1: Baseline characteristics and mode of delivery of women living with HIV (WLWH)  compared with 










Maternal age at delivery, 






African origin, n(%) 218 (56.0) 1,105 (56.8) 0.99 
missing 0 0  
Nulliparous, n(%)  148 (38.7) 715 (36.9) 0.01 
missing (7) (8)  
Birth characteristics 
Mode of delivery 
Vaginal delivery, n(%) 125 (32.1) 1,297 (66.7) 
<0.0001 
Assisted vaginal delivery, n(%)  5 (1.3) 129 (6.6) 
Elective caesarean section, n(%) 158 (40.6) 188 (9.7) 
Emergency caesarean section, n(%) 101 (26.0) 331 (17.0) 
missing (0) (0) 
Abnormal birth presentation, n(%)
2
 206 (53.6) 500 (26) 
<0.0001 
missing (5) (19) 
Gestational age, mean(weeks) 
(95%CI) 
38.7 (38.5-39.9) 39.8 (39.7-39.9 <0.0001 
missing (0) (0)  
Characteristics of children 
Sex, n(%) 
Male 218 (56.6) 1012 (52.0) 
0.09 
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missing (5) (18) 
Maternal HIV characteristics 
Route of transmission, n(%)   
Sexual 273 (70.2) - 
Injection drug use 11 (2.8) - 
Other/missing 105 (27) - 
HIV diagnosis during pregnancy, n(%) 71 (18.2) - 
missing (0) - 
Time from diagnosis of HIV to 
delivery, median (years) (IQR) 
6 (2.0-9.0) 
- 
missing (1) - 
AIDS defining diagnose, n(%) 30 (8.0) - 
missing (16) - 
CD4 cells at delivery, n(%)  - 
≥350 cells/µL 283 (75.9) - 
200-349 cells/µL 68 (18.2) - 
<200 cells/µL 22 (5.9) - 
missing (16) - 
HIV RNA at delivery, n(%)   
 <40 copies/mL 326 (85.6) - 
40-999 copies/mL 49 (12.8) - 
≥ヱヰヰヰ copies/mL 6 (1.6)  
missing (8) - 
Time of ART initiation
3
, n(%) 
Before pregnancy 247 (64.3) - 
Before or at week 14 44 (11.4) - 
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missing (5) - 
ART regimen at delivery
4
, n(%) 
3 NRTIs 22 (5.7) - 
2 NRTIs + 1 NNRTI 46 (11.8) - 
2 NRTIs + PIs 287 (73.8) - 
Other 34 (8.7) - 
Missing (0) - 
Mother to-child-transmission, n(%) 0 (0) - 
1
 The p-values were calculated without correction. The Kruskal-Wallis test was used for the continuous variables and 
the chi-square test was used for the categorical variables. 
2
Abnormal presentation of fetus during birth: face, brow, 
breech and shoulder 
 3
ART, Antiretroviral Treatment;  
4
 NRTIs, Nucleoside/Nucleotide Reverse Transcriptase Inhibitors; 
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Table 2: Maternal risk factors for women living with HIV (WLWH) in Denmark 2002-2014 compared with 
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1
 The p-values were calculated without correction. The χ2 test or Fisher’s exact test was used for the 
categorical variables. 
2 
The test was only performed in multiple parous women 
3 
Viral hepatitis: active and 
chronic hepatitis B and C. 
4
Psychiatric disorders: schizophrenia, depression, anxiety, eating disorder, 
hyperkinetic disorders and others.  
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Table 3: Unadjusted and adjusted odds ratios for pregnancy related complications in women living with HIV (WLWH) and women in the general population (WGP) 
1
Adjusted for viral hepatitis, smoking, psychiatric disorders, age ≥30 years and multi parity. 2Adjusted for viral hepatitis, smoking, psychiatric disorders, age ≥30 
years, multi parity and prematurity. The model is adjusted with HIV, comparing women with HIV to women of the general population regarding the different 




PPROM/PROM = Preterm premature 
rupture of membranes/Premature rupture of membranes; 
3
Hypertensive disorders including pre-eclampsia, eclampsia and hemolysis elevated liver enzymes low 
platelets syndrome (HELLP syndrome).  
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 Adjusted for mode of delivery, smoking, parity, previous caesarean section, age≥30 years and year of birth 2adjusted for parity, smoking, previous caesarean 
section, age≥30 years and period of birth, 3Adjusted for smoking, multiparity, previous caesarean section, age≥30 years and period of birth. The models are adjusted 
with HIV, comparing women with HIV to women of the general population regarding the different complications to birth. The validity of the models was tested using 















Figure 1:  Unadjusted Overall median birth weight and median gestational age in women living with HIV 
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Figure 1a: Unadjusted m Median birth weight and median gestational age in women living with HIV 






















































Vaginal deliveries - Gestational age - WLWH Vaginal deliveries - Gestational age - WGP 
















Figure 1b: Unadjusted mMedian birth weight and median gestational age in women living with HIV (WLWH) 
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Figure 1c: Unadjusted mMedian birth weight and median gestational age in women living with HIV (WLWH) 
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